Spectrascience New Stock Today
PerformanceVery Weak
| Odds Of DistressQuite High
|
Spectrascience New has more than 63 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. SpectraScience, Inc. The company has 4.92 B outstanding shares. More on Spectrascience New
Spectrascience New cannot be verified against its exchange. Apparently, Spectrascience New is not available for investing at the moment. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshSpectrascience Stock Highlights
CEO | Michael Oliver |
Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Appliances & Equipment, Healthcare (View all Sectors) |
Spectrascience New (SCIE) is traded on OTCCE Exchange in USA and employs 5 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.92 K. Spectrascience New conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 4.92 B outstanding shares.
Spectrascience New currently holds about 27.88 K in cash with (1.51 M) of positive cash flow from operations.
Check Spectrascience New Probability Of Bankruptcy
Spectrascience Stock Against Markets
Try Other Suggestions
Spectrascience New Corporate Executives
Elected by the shareholders, the Spectrascience New's board of directors comprises two types of representatives: Spectrascience New inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spectrascience. The board's role is to monitor Spectrascience New's management team and ensure that shareholders' interests are well served. Spectrascience New's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spectrascience New's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lowell Giffhorn | CFO, Principal Accounting Officer and Secretary | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.